Who has invested in Capital Rx?

Wellington Management, General Catalyst, Generation are named among the investors backing Capital Rx.

Capital Rx Funding: $400M Raised, Series F (2025)

Capital Rx funding overview

Capital Rx is based in New York. Capital Rx has raised $400M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series F announced in September 2025. The round record for Capital Rx runs through 2025; nothing later has been disclosed. Investors on record include Wellington Management, General Catalyst, Generation. 3 distinct backers are named across the disclosed rounds.

Capital Rx at a glance

Total raised: $400M
Latest round: Series F
Latest round date: September 2025
Headquarters: New York
Notable investors: Wellington Management, General Catalyst, Generation

Frequently asked about Capital Rx funding

How much has Capital Rx raised?: Capital Rx has raised $400M in total disclosed funding across the rounds on record.
Who has invested in Capital Rx?: Wellington Management, General Catalyst, Generation are named among the investors backing Capital Rx.
What was the latest Capital Rx funding round?: The most recent disclosed round is a Series F, announced in September 2025.
Where is Capital Rx based?: Capital Rx is based in New York.
When did Capital Rx last raise?: The last disclosed Capital Rx round closed in September 2025 at Series F.

Capital Rx totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.

Capital Rx Funding: $400M Raised, Series F (2025)

Capital Rx funding overview

Capital Rx at a glance

Frequently asked about Capital Rx funding

Companies related to Capital Rx (36)

Browse related funding lists (7)